MBAV NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

M3-Brigade Acquisition V Corp. Class A Ordinary shares · Financial Services · Shell Companies

Open interactive chart View report data Download investor PDF
Latest close 11.14 USD
2.4% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 3.8% above the Trend Line and sits at 71.3% of its 52-week range. The latest completed week returned 2.4%, after a 2.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 46/100. Near-term considerations: volume confirmation is below normal.

Setup score 50 out of 100
Latest Close 11.14 USD 24 Jul 2026
1W Return 2.4% latest completed week
4W Return 2.9% short-term follow-through
12W Return 3.2% quarterly tape
Trend Breadth 42.3% 22 of 52 weeks active
Volume Ratio 0.0x vs 13-week average
What is working
  • The trend backdrop is active with a 2-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.4% Latest completed week; four-week move 2.9%. Indicator stack 30/63 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 60.55% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 46/100 48 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 3.8% above the Trend Line and sits at 71.3% of its 52-week range. The latest completed week returned 2.4%, after a 2.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.0x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5112-week average 0.65

12-week confirmation

Trend active7/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.51Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 2.9% over four weeks, 3.2% over 12 weeks, and 4.9% over one year. The current trend has remained active for 2 consecutive weeks.

Performance by holding period

1W2.4%
4W2.9%
12W3.2%
26W4.9%
52W4.9%
Active trend streak2 weeks
Active weeks in one year22
Trend breadth42.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.07Latest activity-pressure read.
Pressure change152.8%Four-week change in activity pressure.
Leadership-4.60Latest relative-leadership reading.
RS change61.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 64% Model confidence 61%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength53/100Blend of value, momentum, and quality. Underlying universe rank 48; rank 1 is best.
Value50/100Relative valuation strength. Underlying universe rank 51; rank 1 is best.
Quality49/100Profitability and accounting quality. Underlying universe rank 52; rank 1 is best.
Momentum51/100Medium-term price momentum. Underlying universe rank 50; rank 1 is best.
Growth51/100Revenue and earnings growth. Underlying universe rank 50; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
87.4x
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-0.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-1.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment46/100

Weighted news tone is neutral across 48 relevant articles.

4 positive · 32 neutral · 12 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-6.9%Distance below the 52-week high.
13-week volatility4.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher17 of 268 weeks finished lower.
Best week+10.8%Week of 19 Jun.
Worst week-9.8%Week of 12 Jun.
Latest week+2.4%Week of 24 Jul.

Shape of recent returns

Strong gains1
Modest gains16
Flat weeks1
Modest losses7
Sharp losses1
Recent vol4.1%13-week weekly-return volatility.
Base vol2.1%52-week weekly-return volatility.
Up/down split29/20Count of positive and negative weeks in the 52-week window.
Average skew0.8% / -0.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape49/100

Trend, activity pressure, participation, and risk combine to a 49/100 tape read.

 Indicator analysis46/100

Latest 12-week confirmation: trend 7/12, activity pressure 8/12, relative leadership 0/12.

Activity pressure 0.51; No reversal markers Next-Week ExpectancyPositive 60.55%

Next-week expectancy is positive with a 60.55% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 50; Small Cap Core rank 54 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment46/100

Weighted news tone is neutral across 48 relevant articles.

M3-Brigade Acquisition V Corp (MBAV) Income Statement Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202611.14 USD2.4%10.73 USD10.57 USD0.07-4.60560On
17 Jul 202610.88 USD0.2%10.72 USD10.56 USD-0.07-8.6167.5KOn
10 Jul 202610.85 USD0.2%10.72 USD10.56 USD-0.01-12.981.1MOff
3 Jul 202610.83 USD0.1%10.72 USD10.56 USD-0.22-12.052.0MOff
26 Jun 202610.82 USD0.2%10.71 USD10.55 USD-0.13-11.941.8MOff
19 Jun 202610.80 USD10.8%10.70 USD10.55 USD0.09-16.556.8MOff
12 Jun 20269.75 USD-9.8%10.70 USD10.55 USD0.16-23.59112.4KOff
5 Jun 202610.81 USD0.0%10.72 USD10.56 USD0.49-14.24152.0KOn
29 May 202610.81 USD0.1%10.71 USD10.56 USD0.67-18.74839.7KOn
22 May 202610.80 USD0.2%10.71 USD10.55 USD0.73-17.1943.0KOn
15 May 202610.78 USD-0.2%10.70 USD10.55 USD0.92-16.8317.2KOn
8 May 202610.80 USD0.1%10.69 USD10.55 USD1.34-17.37661.1KOn
1 May 202610.79 USD-0.0%10.69 USD10.54 USD1.61-13.454.9KOn
24 Apr 202610.79 USD-1.1%10.68 USD10.54 USD1.59-12.5815.7KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.